Division of Cardiovascular Diseases

Interventional Cardiovascular Diseases Fellowship

Overview from the program director

The interventional cardiology fellowship at the University of Kansas Medical Center (KUMC) is a one-year program designed to prepare the trainee for a career in academic as well as clinical interventional cardiology. The program is ACGME accredited and fulfills all ACGME mandated requirements for training. This is the only accredited interventional cardiology training program in the state of Kansas.
The fellowship is entirely based at the University of Kansas Hospital, which is the primary teaching hospital for the University. This is a 456-bed academic tertiary care referral center for the Kansas City metropolitan area and gets patients from a tri state region. The Center for Advance Cardiac Care is housed within the KU hospital and is a state of the art facility that provides an ideal environment for interventional training. The center houses five modern and fully equipped cardiac catheterization laboratories (two of these are state of the art hybrid suites with open heart capabilities). The catheterization laboratories have fully integrated invasive diagnostic modalities such as intravascular ultrasound and optical coherence tomography. The annual volume for interventional cardiology services is approximately 800 coronary interventions, over 300 vascular procedures and over 300 structural heart cases. KU is also a center of excellence for training for fractional flow reserve and optical coherence tomography and thus we gave a large volume of cases in these procedures also. The program offers exposure to a wide variety of procedures including most currently available investigational devices. The structural program performs most available procedures including about 200 transcatheter aortic valve procedures and other procedures such as mitral clip, left atrial occlusions, PFO/ ASD/ VSD closures and a variety of valvuloplasties including pulmonary valve procedures. Our coronary case mix also allows for training in advance techniques. Due to a busy valve program we have a high volume of multi-vessel coronary interventions in the elderly populations resulting in frequent use of various coronary atherectomy devices and of percutaneous cardiac assist devices. Thus, even though the ACGME accredited fellowship is geared towards providing an exceptional coronary training (all past fellows have graduated with over 350 coronary interventions) all fellows also get a good exposure to non-coronary procedures (average number of peripheral cases performed during fellowship is 150 cases). Since we choose to accept only one interventional fellow each year, the training opportunities abound without competition for cases amongst trainees. Fellows are free to choose the cases they scrub into.
The core-teaching faculty comprises of six full time board certified interventional cardiologists who are dedicated to the training of our fellows. Each faculty is a high volume coronary interventionalist but also has a specific area of expertise such as peripheral or structural. Thus our fellows learn from very experienced faculty. The daily work environment is very friendly and is geared towards optimization of workflow and learning. This is possible due to a large number of very experienced mid-level staff in our team that helps facilitate smooth work flow.
The interventional service is involved in a large number of research studies including device studies that allows for our trainees to be exposed to new and emerging technologies. The Cardiovascular Research Institute offers state-of-the-art facilities and infrastructure for basic, clinical, or translational cardiovascular research. A number of physicians within the division are actively engaged in numerous investigator-initiated projects also. Fellows are strongly encouraged to initiate and participate in innovative projects, present at conferences, and publish.
There are a variety of educational opportunities by way of didactic and other conferences. Conferences are held at 7 AM, on Monday, Tuesday, Thursday, and Friday. The Internal Medicine grand rounds are held on Wednesday mornings at 8 AM. Interventional fellows lead the Interventional Journal Club once month and also lead a hemodynamics conference. There is a separate noninvasive imaging conference at noon on Thursday and research conferences every third Wednesday of the month at 7 AM.
Thus, in summary the Interventional Cardiology Training program at KUMC provides a high quality interventional training in a very supportive academic environment with exposure to a wide variety of cases in all sub areas of our specialty. Our first time board pass rate is 100% and all are graduates have been immensely successful in their chosen careers.

Interventional Cardiology Fellowship Applicants
Please contact: Anna Bryan, for applications, questions or concerns
Email: abryan@kumc.edu

Faculty

K Gupta Kamal Gupta, M.D., FACC, FSCAI, R.P.V.I.
Program Director
Associate Professor of Medicine - Cardiology
Director, Vascular Medicine Program Mid America Cardiology
M Earnest Matthew B. Earnest, M.D., F.A.C.C., F.S.C.A.I.
Clinical Assistant Professor of Medicine - Cardiology
R Genton Randall E. Genton, M.D., F.A.C.C.
Associate Professor of Medicine - Cardiology
A Mehta Ashwani Mehta, M.D., M.B.B.S., F.A.C.C.
Clinical Assistant Professor of Medicine - Cardiology
P Tadros Peter N. Tadros, M.D., F.A.C.C., F.S.C.A.I., F.A.S.E
Assistant Professor of Medicine - Cardiology
Mark Wiley Mark A. Wiley, M.D., F.A.C.C., F.S.C.A.I
Assistant Professor of Medicine - Cardiology

 

Current Fellows

Prasad Gunasekaran

Prasad Gunasekaran, MBBS
Interventional Cardiovascular Fellow

Medical School: K.A.P. Vishwanathan Government Medical College, Trichy
Residency: Wayne State University/Detroit Medical Center, Detroit, MI 

Research Interests: Outcomes research, predictors of stent thrombosis and speckle tracking echocardiograpy  

Peer Reviewed Publications: 

  • Stanojevic D, Gunasekaran P, Tadros P, Wiley M, Earnest M, Mehta A, Lippmann M, Levine M, Dawn B, Gupta K. Intravenous Adenosine Infusion is Safe and Well Tolerated During Coronary Fractional Flow Reserve Assessment in Elderly Patients With Severe Aortic Stenosis. J Invasive Cardiol. 2016 Sep;28(9):357-61. Epub 2016 Jun 15. PMID: 27315577.
  • Gunasekaran P, Panaich S, Briasoulis A, Cardozo S, Afonso L. Incremental Value of Two Dimensional Speckle Tracking Echocardiography in the Functional Assessment and Characterization of Subclinical Left Ventricular Dysfunction. Curr Cardiol Rev. 2016 Jul 11. [Epub ahead of print]. PMID: 27411342.
  • Gunasekaran P, Parashara D. Heterogeneity in the Perioperative Management of Non-Vitamin K Oral Anticoagulants in Chronic Kidney Disease. Journal of Atrial Fibrillation, January 2016.
  • Afonso L, Arora NP, Mahajan N, Kottam A, Ballapuram K, Toosi M, Bhandare D, Gunasekaran P, Mitiku T, Williams KA. Comparison of patients with peripartum heart failure and normal (≥55%) versus low (<45%) left ventricular ejection fractions. Am J Cardiol 2014;114:290-3. PMID: 24874163.
  • Zalawadiya SK, Gunasekaran PC, Bavishi CP, Veeranna V, Panaich S, Afonso L. Left ventricular hypertrophy and risk reclassification for coronary events in multi-ethnic adults. Eur J Prev Cardiol 2014. Apr 3. [Epub ahead of print]. PMID:    24699336
  • Manickam P, Krishnamoorthi R, Kanaan Z, Gunasekaran PC, Cappell MS. Prognostic implications of recipient or donor hepatitis B seropositivity in thoracic transplantation: analysis of 426 hepatitis B surface antigen-positive recipients. Transpl Infect Dis 2014;16:597-604. PMID: 25017710
  • Cardozo S, Gunasekaran P, Patel H, McGorisk T, Toosi M, Faraz H, Zalawadiya S, Alesh I, Kottam A, Afonso L. "Is bacteriostatic saline superior to normal saline as an echocardiographic contrast agent?". Int J Cardiovasc Img. June 2014. PMID: 25017710.
  • Gunasekaran P, Muthusamy A, Kanaan Z, Krishnamoorthi R, Palani G, Manickam P. Association of Inflammatory Bowel Disease with Coronary Artery Disease: Fact or Fiction? Volume 2 Issue 2 Immuno-Gastroenterology 2:2, 114-118; April/May/June 2013.
  • Manickam P, Gunasekaran P, Sudhakar R, Veeranna V, Afonso L. Association of Helicobacter pylori seropositivity with all-cause mortality: fact or fiction?: Multi-Ethnic Study of Atherosclerosis. Gut 2013. PMID: 23633293.

 Peer Reviewed Abstracts/Poster Presentations:

  • Gunasekaran P, Bickel T, Parashara, D. Use of Mechanical Circulatory Support Leading to Heart Transplant is Associated With Strokes in the Immediate Post-Transplant Period: Analysis of 59,170 Heart Transplants From the UNOS Database. Annual Scientific Session of the American College of Cardiology, November 2015.
  • Gunasekaran P. Insurance Pre-Authorization Delays and the Need for Standardization and Transparency: How Can Local Chapters and FITs Make a Difference? http://www.acc.org/membership/sections-and-councils/fellows-in-training-section/fit-information-hub/advocacy/2016/08/25/15/43/insurance-pre-authorization-delays-and-the-need-for-standardization-and-transparency
  • Elder M, Mohamad T, Kaki A, Gunasekaran P. Utility of the TruePath Device in the Endovascular Treatment of Chronic Total Arterial Occlusions. Journal of Vascular and Interventional Radiology. 25(1):155e12, Jan 2014
  • Zubair Shah; Rashmi Thapa; Mashood Wani; Suresh Sharma; Taylor Myers; Kamalakar Surineni; Chris Johnson; Lauren Penn; John Fritzlen; Reza Masoomi; Prasad Gunasekaran; G. John Chen; Buddhadeb Dawn; Kamal Gupta. Effect of aggressive lipid therapy on progression of carotid artery stenosis: a longterm follow up study. J Am Coll Cardiol. 2015;65(10_S):.  doi:10.1016/S0735-1097(15)61487-5.
  • Dusan A. Stanojevic; Prasad Gunasekaran; Micah Levine; Mark Reichuber; Randall Genton; Ashwani Mehta; Matthew Earnest; Mark Wiley; Peter Tadros; Buddhadeb Dawn; Kamal Gupta. Intravenous adenosine infusion is safe and well tolerated during coronary fractional flow reserve assessment in severe aortic stenosis. J Am Coll Cardiol. 2015;65(10_S):.  doi:10.1016/S0735-1097(15)61931-3.
  • Gunasekaran P, Muthusamy A, Elder M. Factors Influencing Discharge Against Medical Advice in Patients with Chest Pain. Journal of the American College of Cardiology 2013;61. Poster presented at the annual scientific session of the American College of Cardiology, San Francisco, March 2013.
  • Muthusamy A, Gunasekaran P, Manickam P, Krishnamoorthi R. Is Inflammatory Bowel Disease a Risk Factor for Developing Coronary Artery Disease? Gastroenterology 2013;144:S-636. Poster presented at the DDW, Orlando, FL 2013.
  • Gunasekaran P, Manickam P, Afonso L. Lack of Association between Helicobacter pylori Seropositivity and the Progression of Subclinical Atherosclerosis in Healthy Adults. Presented at the American College of Physicians Annual Scientific Meeting, Bellaire, MI, September 2013.
  • Gunasekaran P, Manickam P, Husain M, Afonso L. Favourable Effect of Helicobacter Pylori on Serum Lipid Profile. Presented at the American College of Physicians Annual Scientific Meeting, Bellaire, MI, September 2013.
  • Gunasekaran P, Manickam P, Husain M, Afonso L. Inflammatory Biomarkers are Associated with Left Ventricular Hypertrophy. Presented at the American College of Physicians Annual Scientific Meeting, Bellaire, MI, September 2013.
  • Manickam P, Sudhakar R, Krishnamoorthi R, Gunasekaran P, Rathod A, Chopra T, Dror S, Kaye K. Outcomes in Patients with Severe Pulmonary Infections prior to Heart-Lung Transplantation. Poster presentation at the annual meeting of SHEA, Dallas, April 2011.

 

 


 

Last modified: Jul 17, 2017
ID=x2851